Newall F - Search Results

1

Anti-activated factor II assay for monitoring unfractionated heparin in children: results of the HEARTCAT study.

Hanslik A, Kitzmüller E, Tran US, Thom K, Karapetian H, Prutsch N, Voitl J, Michel-Behnke I, Newall F, Male C. Hanslik A, et al. Among authors: newall f. J Thromb Haemost. 2017 Jan;15(1):38-46. doi: 10.1111/jth.13539. Epub 2016 Nov 25. J Thromb Haemost. 2017. PMID: 27736032 Free article. Clinical Trial.

2

Point of care monitoring of oral anticoagulant therapy in children: comparison of CoaguChek Plus and Thrombotest methods with venous international normalised ratio.

Ignjatovic V, Barnes C, Newall F, Hamilton S, Burgess J, Monagle P. Ignjatovic V, et al. Among authors: newall f. Thromb Haemost. 2004 Oct;92(4):734-7. doi: 10.1160/TH04-02-0085. Thromb Haemost. 2004. PMID: 15467903

3

Age-related differences in heparin response.

Ignjatovic V, Furmedge J, Newall F, Chan A, Berry L, Fong C, Cheng K, Monagle P. Ignjatovic V, et al. Among authors: newall f. Thromb Res. 2006;118(6):741-5. doi: 10.1016/j.thromres.2005.11.004. Epub 2005 Dec 19. Thromb Res. 2006. PMID: 16360197

4

In vivo age dependency of unfractionated heparin in infants and children.

Newall F, Ignjatovic V, Summerhayes R, Gan A, Butt W, Johnston L, Monagle P. Newall F, et al. Thromb Res. 2009 Mar;123(5):710-4. doi: 10.1016/j.thromres.2008.07.009. Epub 2008 Sep 30. Thromb Res. 2009. PMID: 18829072

5

Unfractionated heparin therapy in infants and children.

Newall F, Johnston L, Ignjatovic V, Monagle P. Newall F, et al. Pediatrics. 2009 Mar;123(3):e510-8. doi: 10.1542/peds.2008-2052. Epub 2009 Feb 16. Pediatrics. 2009. PMID: 19221154 Review.

6

Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).

Greenway A, Ignjatovic V, Summerhayes R, Newall F, Burgess J, DeRosa L, Monagle P. Greenway A, et al. Among authors: newall f. Thromb Haemost. 2009 Jul;102(1):159-65. doi: 10.1160/TH09-01-0056. Thromb Haemost. 2009. PMID: 19572081 Clinical Trial.

7

Age is a determinant factor for measures of concentration and effect in children requiring unfractionated heparin.

Newall F, Ignjatovic V, Johnston L, Summerhayes R, Lane G, Cranswick N, Monagle P. Newall F, et al. Thromb Haemost. 2010 May;103(5):1085-90. doi: 10.1160/TH09-09-0624. Epub 2010 Feb 19. Thromb Haemost. 2010. PMID: 20174762

8

The in vitro response to low-molecular-weight heparin is not age-dependent in children.

Ignjatovic V, Summerhayes R, Newall F, Monagle P. Ignjatovic V, et al. Among authors: newall f. Thromb Haemost. 2010 Apr;103(4):855-6. doi: 10.1160/TH09-10-0687. Epub 2010 Feb 19. Thromb Haemost. 2010. PMID: 20174765 No abstract available.

9

Dosing and monitoring of enoxaparin (Low molecular weight heparin) therapy in children.

Ignjatovic V, Najid S, Newall F, Summerhayes R, Monagle P. Ignjatovic V, et al. Among authors: newall f. Br J Haematol. 2010 Jun;149(5):734-8. doi: 10.1111/j.1365-2141.2010.08163.x. Epub 2010 Mar 21. Br J Haematol. 2010. PMID: 20346012 Free article.

10

Clinical use of unfractionated heparin therapy in children: time for change?

Newall F, Ignjatovic V, Johnston L, Summerhayes R, Lane G, Cranswick N, Monagle P. Newall F, et al. Br J Haematol. 2010 Sep;150(6):674-8. doi: 10.1111/j.1365-2141.2010.08302.x. Br J Haematol. 2010. PMID: 20629660 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters